-
Symbol
-
LXEO on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
2.77M shares
-
Security Ownership
-
3.8%
Longitude Capital Partners IV, LLC ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)
2025-11-14 - Longitude Capital Partners IV, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.77M shares of Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO).
This represents 3.8% percent ownership of the company.